Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEGN | BMY | AMGN | GILD | REGN |
| Company | Legend Biotech Corp ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 51.04 | 49.29 | 335.15 | 83.26 | 1,145.99 |
| High | 51.32 | 49.53 | 338.19 | 83.76 | 1,149.42 |
| Low | 49.50 | 49.06 | 334.27 | 82.75 | 1,141.87 |
| Last | 49.89 | 49.44 | 337.96 | 83.54 | 1,146.43 |
| Change | -0.94 | +0.42 | +2.01 | -0.36 | -3.76 |
| % Change | -1.85% | +0.86% | +0.60% | -0.43% | -0.33% |
| Volume | 118,817 | 6,418,750 | 1,021,443 | 3,479,319 | 144,854 |
| 20-Day Average Volume | 682,500 | 8,407,844 | 1,698,495 | 6,546,233 | 410,864 |
| Previous Close | 50.83 | 49.02 | 335.95 | 83.90 | 1,150.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 53.15 | 49.17 | 330.16 | 80.44 | 1,163.31 |
| 20-Day Raw Stochastic | 15.91% | 58.16% | 85.20% | 83.07% | 30.93% |
| 20-Day Relative Strength | 41.52% | 55.41% | 57.74% | 69.18% | 51.23% |
| Weighted Alpha | -21.53 | -10.40 | +27.14 | +17.21 | +39.99 |
| Today's Opinion | 40% Sell | 72% Buy | 100% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 24% Sell | 56% Buy | 96% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 56% Buy | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.35% since 09/13/24 | +0.48% since 09/13/24 | +1.38% since 09/13/24 | +0.68% since 09/13/24 | -0.85% since 09/13/24 |
| Low | 49.63 on 09/20/24 | 48.78 on 09/18/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 1,134.59 on 09/17/24 |
| High | 52.31 on 09/16/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 1,165.85 on 09/19/24 |
| 1-Month | |||||
| %Chg | -13.02% since 08/20/24 | +0.79% since 08/20/24 | +2.59% since 08/20/24 | +11.53% since 08/20/24 | -4.08% since 08/20/24 |
| Low | 47.74 on 09/06/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 1,113.24 on 09/11/24 |
| High | 59.62 on 09/03/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +21.64% since 06/20/24 | +20.29% since 06/20/24 | +8.76% since 06/20/24 | +21.73% since 06/20/24 | +9.49% since 06/20/24 |
| Low | 40.63 on 06/21/24 | 39.35 on 07/05/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 1,011.67 on 07/03/24 |
| High | 60.87 on 07/25/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | -17.32% since 03/20/24 | -4.85% since 03/20/24 | +23.44% since 03/20/24 | +12.69% since 03/20/24 | +18.26% since 03/20/24 |
| Low | 38.60 on 06/03/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 60.90 on 03/21/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,265,446 | 99,368,440 | 180,215,344 | 104,527,072 | 126,734,816 |
| Shares Outstanding, K | 182,283 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 285,140,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -518,250,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 186,520,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -18,200,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | 0.11 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/09/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/09/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 17.85 | 29.64 |